New Zealand markets closed

Microbot Medical Inc (CY9D.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.9445-0.0030 (-0.32%)
As of 10:51AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
8,108
5,724
7,736
6,153
3,396
-
Selling general and administrative
5,930
4,317
5,581
5,096
5,563
-
Total operating expenses
14,150
10,136
13,437
11,357
9,089
-
Operating income or loss
-14,150
-10,136
-13,437
-11,357
-9,089
-
Interest expense
-
-
-
-
80
103
Total other income/expenses net
-
-887
215
44
-
96
Income before tax
-14,029
-10,740
-13,168
-11,313
-9,169
-
Income from continuing operations
-14,029
-10,740
-13,168
-11,313
-9,169
-
Net income
-14,029
-10,740
-13,168
-11,313
-9,169
-
Net income available to common shareholders
-14,029
-10,740
-13,168
-11,313
-9,169
-
Basic EPS
-1.29
-1.05
-1.81
-1.59
-1.29
-
Diluted EPS
-1.29
-1.05
-1.81
-1.59
-1.29
-
Basic average shares
7,118
10,200
7,260
7,108
7,118
-
Diluted average shares
7,118
10,200
7,260
7,108
7,118
-